CUV:ASX
Clinuvel Pharmaceuticals Ltd
A$7,55
arrow_upward
+1,75%(+0,13) 1D
11 Nov., 16:10:09 GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CUV...
Open
A$7,40
High
A$7,76
Low
A$7,40
Mkt. cap
381,18 m
Avg. vol.
154,28 k
Volume
204,17 k
Dividend
0,66%
Quarterly dividend
A$0,01
Ex-dividend date
03 Sep. 2026
P/E ratio
11,30
52-wk high
A$13,48
52-wk low
A$6,62
EPS
A$0,67
Shares outstanding
50,49 m
No. of employees
16
Open
A$7,40
High
A$7,76
Low
A$7,40
Mkt. cap
381,18 m
Avg. vol.
154,28 k
Volume
204,17 k
Dividend
0,66%
Quarterly dividend
A$0,01
Ex-dividend date
03 Sep. 2026
P/E ratio
11,30
52-wk high
A$13,48
52-wk low
A$6,62
EPS
A$0,67
Shares outstanding
50,49 m
No. of employees
16
News stories
From web sources and news partners
Trefis
·
57 minute gelede
Is Your S&P 500 Fund A Bet On 7 CEOs?
TradingView
·
2 uur gelede
SPX: S&P 500 Futures Rise as Volatile Trading Continues, AI Rebound Faces a Near-5% Yield
Investing.com
·
39 minute gelede
The S&P 500 Has an Nvidia Problem
BigGo Finance
·
5 uur gelede
UBS Sees S&P 500 at 8,900 by End-2027 as BofA Flags Crowded Index Trade
About Clinuvel Pharmaceuticals Ltd
CEOPhilippe J. Wolgen
Employees16
Founded1987
Headquarters-
SectorHealth Care
Industry-
Websiteclinuvel.com